Skip to main content
IDCases logoLink to IDCases
. 2018 Jun 30;14:e00415. doi: 10.1016/j.idcr.2018.e00415

Pneumococcal urinary antigen test: A tool for pneumococcal aortitis diagnosis?

Stanislas Abrard a,, Benoit Cousin a, Thomas Reydel a, Myriam Ammi b, Laurent Beydon a
PMCID: PMC6037901  PMID: 29998060

Abstract

Introduction

Aortitis is rare. The etiological diagnosis is difficult but essential for treatment. Even with appropriate treatment mortality remains high. We present a case of pneumococcal aortitis followed by a brief review of the literature.

Presentation of Case

In this case, the aortic disease was characterized by multiple inflammatory aneurysms. Blood cultures were negative but urine was tested for the presence of pneumococcal urinary antigen postoperatively was positive. Treatment consisted of antibacterial therapy and both surgical and endovascular procedures. The patient was discharged and is well.

Discussion

Preoperative determination of etiology is crucial in implementing a specific treatment. Pneumococcus is a common bacterium in infectious aortitis. Identification of the causative microbe is necessary to guide antimicrobial therapy. Blood cultures are frequently sterile. The pneumococcal urinary antigen test may be more sensitive than blood cultures, as is the case in pneumococcal pneumonia.

Conclusions

The pneumococcal urinary antigen test may was a useful diagnostic tool in establishing the cause for aortitis in this case. Its potential value should be assessed in furthers studies.

Keywords: Aortitis, Aneurysm infected, Diagnosis, Streptococcus pneumoniae, Pneumococcal infections

Introduction

Aortitis has various etiologies, most common being vasculitis, and infectious. An etiological determination is crucial in implementing specific treatment. Diagnosis involves imaging and nuclear medicine techniques. An inflammatory or infectious cause should be differentiated after identification of aortitis [1] and may be difficult. Mycotic aneurysm is a rare subset of aneurysms (0.06–2.6%) and has amortality rate that can reach 25% even with adequate therapy [[2], [3], [4]].

The pneumococcal urinary antigen test is commonly used to increase diagnosis in cases of pneumonia. We present a case with pneumococcal aortitis and found this diagnostic tool useful in establishing the cause for aortitis.

Case report

A 53-year-old woman presented with lumbar pain suggestive of a kidney stone. She was a frequent smoker, suffered from alcoholism, had undergone cervical conization and was in remission of anal margin cancer after radiotherapy and chemotherapy. There was no history of fever. A CT without contrast did not find evidence of kidney stone. The patient was hospitalized for persistent pain and raised levels of inflammatory markers (leukocytosis at 9.5 × 109/L and C reactive protein at 129 mg/L). Subsequently, a CT angiography showed three separate aortic aneurysms with surrounding inflammatory processes: two in the abdominal aorta (Fig. 1A) and one in the thoracic aorta (Fig. 1B). Positron Emission Tomography using Fluorinated Desoxyglucose (FDG-PET) and Labelled Leucocyte Scintigraphy (LLS) were suggestive of a septic process in the thoracic aorta aneurysm and in the abdominal aorta aneurysm located below the left renal artery (hypermetabolic activity with LLS in agreement with FDG-PET) (Fig. 2). Transthoracic echocardiography found no valvular lesion.

Fig. 1.

Fig. 1

CT angiography. A: Initial CT angiography showing abdominal aortic aneurysm upstream of the coeliac axis (28 × 23 × 29 mm) in axial view. B: Initial CT angiography finding an aneurysm on the descending thoracic aorta (18 × 9 mm and 22 mm in height) with an inflammatory aspect as observed in coronal view. C: Control CT angiography 9 days after surgery showing an increase in size of the abdominal aorta infrarenal aneurysm (10 × 8 × 10 mm) in axial view. D: Control CT angiography 3-dimensional reconstruction.

Fig. 2.

Fig. 2

Nuclear medicine images of the descending thoracic aorta. A. Fluorinated Desoxyglucose Scintigraphy has shown a paravertebral hypermetabolic activity. B. Positron Emission Tomography using Fluorinated Desoxyglucose (FDG-PET) showing the origin of this hyperactivity located on aneurysm of the descending thoracic aorta. C. Activity has shown on aneurysm of the descending thoracic aorta with Labelled Leucocyte Scintigraphy (LLS) in agreement with FDG-PET, suggestive of a septic process in the thoracic aorta aneurysm with adjacent infiltration.

Serial blood cultures yielded no growth. Step by step surgical management was elected 19 days after admission. A surgical debridement of the abdominal aorta aneurysm upstream of the celiac axis was performed. An aorto-aortic bypass was performed with cryo-conserved aortic allograft in an interposition at the thoracoabdominal junction. Empiric antibacterial therapy by piperacillin/tazobactam, gentamicin, and vancomycin was initiated. The postoperative course was uncomplicated. Urinary pneumococcal antigen was positive and intraoperative specimens report Streptococcus. pneumonia. Antibacterial therapy was changed to cefotaxime (for 4 weeks) and gentamicin (for 2 weeks). A CT 9 days after surgery showed an increased size of the two aneurysms (Fig. 1.C.D). Two weeks after the first surgery an endovascular procedure to exclude the descending thoracic aortic aneurysm was conducted. Finally, 4 weeks after the first surgery, infrarenal aortic replacement by allograft cryo-conserved was performed. The surgical specimen remained sterile. The postoperative course was uneventful. The patient was discharged with oral amoxicillin for 3 months (amoxicillin) after recovering her normal diet.

Discussion

Mycotic aneurysms are usually solitary, but multiple locations have already been described [5,6]. Atheromas appear to be the main risk factor for subsequent infection [3]. Several mechanisms have been considered, the most common being bacteremic seeding leading to weakness of the aortic intima. Primary pneumonia has been suggested as a source for pneumococcus [3]. Others risk factors include steroid or other immunosuppressive agents use, alcoholism, chronic renal failure, and diabetes [7]. Staphylococcal species, salmonella species and Streptococcus pneumoniae (12%) are the most frequently encountered microorganisms [4,8]. The classical clinical picture includes fever, chest, back or abdominal pain associated with an inflammatory biological syndrome occur in 33% of cases [2]. Aneurysm rupture represents the main risk and can occur without preceding dilation [3].

The immediate or delayed surgical management includes resection of the septic aortic pseudoaneurysm [6]. The bypass can be achieved with a prosthetic graft or an in situ allograft [2] with no superiority of one over the other [9]. Graft infection is a known risk of the procedure [5].

Small case series have demonstrated the feasibility of endovascular treatment [[10], [11], [12]] with survival rates varying from 40 to 82%. Additional surgical treatment such as debridement or percutaneous drainage is protective but not essential [10].

Fever at the time of the surgical procedure is predictive of persistent endovascular graft infection [13]. Antibacterial therapy is a key element of the preoperative management. Identification of the causative microbe is necessary to guide antimicrobial therapy and thus eliminate vasculitis. Antibacterial therapy alone is sufficient only in rare cases [1].

The early identification of an infectious agent is crucial. Patients frequently receive inappropriate therapy due to delayed diagnosis (e.g. use of corticosteroids for suspected inflammatory aneurysms) [14]. Conventional microbiological techniques have low sensitivity. Blood cultures are positive in 40–60% of cases [3,4]. Intraoperative specimens culture can also be misleading because they are only positive in 10–75% of cases [3]. Molecular biology techniques may be of interest but can only be used postoperatively.

In acute community-acquired pneumonia, Binax NOW S. pneumoniae assay, a pneumococcal urinary antigen test, has increased the etiological diagnosis to values varying between 39 and 50% [[15], [16], [17]]. Estimated sensitivity and specificity were 74% and 97%, respectively [18]. The assets of this technique are its rapidity (15 min), simplicity and ability to detect pneumococci even after antimicrobial administration [19]. This test may be used in the preoperative assessment of inflammatory aneurysms. Concurrent vasculitis, endocarditis, and syphilis should also be investigated. Aortitis is more likely to be bacteremic than pneumonia because it is a located infection in the vascular system. Sensitivity was reported to be higher for bacteremic pneumococcal pneumonia than for non-bacteremic cases [20]. The pneumococcal urinary antigen test may be more sensitive than blood cultures, as is the case in pneumococcal pneumonia. The lower sensitivity of blood cultures could be explained by the need for higher concentration of circulating bacteria, the use of antibacterial therapy and histological presentation with vascular wall micro-abscesses that are not directly in contact with bloodstream. This positive test should lead to utilize antimicrobial therapy with good activity against the pneumococcus and, if possible, wait for apyrexia before surgical management. Future research should assess the value of this diagnostic test.

In summary, in infectious aortitis blood cultures may be sterile and the etiological diagnosis is often made post-operatively with the samples collected during surgery. Pneumococcus is one of the three most common germs implicated. Early identification allows targeted antibiotic therapy, a major element for treatment effectiveness. Even with appropriate treatment mortality remains high. Early detection of pneumococcus with a urinary pneumococcus antigen test might improve the treatment success rate. Therefore we suggest the use of this test in patients presenting with aneurysms and fever or whose CT scan suggest an inflammatory process associated with the aneurysm.

Ethical approval

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Conflict of interest

The authors declare that they have no conflicts of interest concerning this article.

Acknowledgments

The authors are grateful to Sophie Sage DVM of Tufts University, Massachusetts USA, for providing language help.

Footnotes

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Contributor Information

Stanislas Abrard, Email: stanislas.abrard@chu-angers.fr.

Benoit Cousin, Email: benoit.cousin@chu-angers.fr.

Thomas Reydel, Email: Thomas.Reydel@chu-angers.fr.

Myriam Ammi, Email: myriam.ammi@chu-angers.fr.

Laurent Beydon, Email: lbeydon.angers@invivo.edu.

References

  • 1.Hoogendoorn E.H., Oyen W.J., van Dijk A.P., van der Meer J.W. Pneumococcal aortitis, report of a case with emphasis on the contribution to diagnosis of positron emission tomography using fluorinated deoxyglucose. Clin Microbiol Infect. 2003;9:73–76. doi: 10.1046/j.1469-0691.2003.00563.x. [DOI] [PubMed] [Google Scholar]
  • 2.Hsu R.B., Chen R.J., Wang S.S., Chu S.H. Infected aortic aneurysms: clinical outcome and risk factor analysis. J Vasc Surg. 2004;40:30–35. doi: 10.1016/j.jvs.2004.03.020. [DOI] [PubMed] [Google Scholar]
  • 3.Cartery C., Astudillo L., Deelchand A., Moskovitch G., Sailler L., Bossavy J.P. Abdominal infectious aortitis caused by Streptococcus pneumoniae: a case report and literature review. Ann Vasc Surg. 2011;25(266) doi: 10.1016/j.avsg.2010.07.014. e9-16. [DOI] [PubMed] [Google Scholar]
  • 4.Gornik H.L., Creager M.A. Aortitis Circul. 2008;117:3039–3051. doi: 10.1161/CIRCULATIONAHA.107.760686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Coutu M., Blair J.F. Multiple mycotic aortic aneurysms due to Streptococcus pneumoniae. Ann Vasc Surg. 2003;17:554–557. doi: 10.1007/s10016-003-0046-6. [DOI] [PubMed] [Google Scholar]
  • 6.Koganti D., Ryan S.P., Kwon J., Abai B., Dimuzio P.J., Salvatore D.M. A typical Mycotic Aortic Aneurysms. Ann Vasc Surg. 2016;36(296) doi: 10.1016/j.avsg.2016.04.008. e13-296.e18. [DOI] [PubMed] [Google Scholar]
  • 7.Steig T.A., Johannesen N., Schønheyder H.C. Propensity of Streptococcus pneumoniae for the aorta. Report of 3 cases. Scand J Infect Dis. 2001;33:772–774. doi: 10.1080/003655401317074617. [DOI] [PubMed] [Google Scholar]
  • 8.Cinà C.S., Arena G.O., Fiture A.O., Clase C.M., Doobay B. Ruptured mycotic thoracoabdominal aortic aneurysms: a report of three cases and a systematic review. J Vasc Surg. 2001;33:861–867. doi: 10.1067/mva.2001.111977. [DOI] [PubMed] [Google Scholar]
  • 9.Bisdas T., Wilhelmi M., Haverich A., Teebken O.E. Cryopreserved arterial homografts vs silver-coated Dacron grafts for abdominal aortic infections with intraoperative evidence of microorganisms. J Vasc Surg. 2011;53:1274–1281. doi: 10.1016/j.jvs.2010.11.052. e4. [DOI] [PubMed] [Google Scholar]
  • 10.Buimer M.G., Bloemsma G.C., van Oostayen J.A., Reijnen M.M. Endovascular repair of a Streptococcus pneumonia-induced aortitis complicated by an iliacocaval fistula. Vasc Endovasc Surg. 2012;46:570–574. doi: 10.1177/1538574412456307. [DOI] [PubMed] [Google Scholar]
  • 11.Kan C.D., Yen H.T., Kan C.B., Yang Y.J. The feasibility of endovascular aortic repair strategy in treating infected aortic aneurysms. J Vasc Surg. 2012;55:55–60. doi: 10.1016/j.jvs.2011.07.077. [DOI] [PubMed] [Google Scholar]
  • 12.Clough R.E., Black S.A., Lyons O.T., Zayed H.A., Bell R.E., Carrell T. Is endovascular repair of mycotic aortic aneurysms a durable treatment option? Eur J Vasc Endovasc Surg. 2009;37:407–412. doi: 10.1016/j.ejvs.2008.11.025. [DOI] [PubMed] [Google Scholar]
  • 13.Kan C.D., Lee H.L., Yang Y.J. Outcome after endovascular stent graft treatment for mycotic aortic aneurysm: a systematic review. J Vasc Surg. 2007;46:906–912. doi: 10.1016/j.jvs.2007.07.025. [DOI] [PubMed] [Google Scholar]
  • 14.Teng W., Sarfati M.R., Mueller M.T., Kraiss L.W. Pneumococcal aortitis: a difficult preoperative diagnosis. J Vasc Surg. 2006;43:177–179. doi: 10.1016/j.jvs.2005.08.018. [DOI] [PubMed] [Google Scholar]
  • 15.Genné D., Siegrist H.H., Lienhard R. Enhancing the etiologic diagnosis of community-acquired pneumonia in adults using the urinary antigen assay (Binax NOW) Int J Infect Dis. 2006;10:124–128. doi: 10.1016/j.ijid.2005.03.006. [DOI] [PubMed] [Google Scholar]
  • 16.Huijts S.M., Pride M.W., Vos J.M., Jansen K.U., Webber C., Gruber W. Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia. Eur Respir J. 2013;42:1283–1290. doi: 10.1183/09031936.00137412. [DOI] [PubMed] [Google Scholar]
  • 17.Choi M.J., Song J.Y., Cheong H.J., Jeon J.H., Kang S.H., Jung E.J. Clinical usefulness of pneumococcal urinary antigen test, stratified by disease severity and serotypes. J Infect Chemother. 2015;21:672–679. doi: 10.1016/j.jiac.2015.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sinclair A., Xie X., Teltscher M., Dendukuri N. Systematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae. J Clin Microbiol. 2013;51:2303–2310. doi: 10.1128/JCM.00137-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–72. doi: 10.1086/511159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Song J.Y., Eun B.W., Nahm M.H. Diagnosis of pneumococcal pneumonia: current pitfalls and the way forward. Infect Chemother. 2013;45:351–366. doi: 10.3947/ic.2013.45.4.351. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from IDCases are provided here courtesy of Elsevier

RESOURCES